Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 4.935
+0.040 (0.82%)
Mar 5, 2026, 5:00 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 73.74 million as of March 5, 2026. Its market cap has decreased by -24.70% in one year.
Market Cap
73.74M
Enterprise Value
68.47M
Revenue
15.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.94
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 73.74M, a decrease of -33.29%. That is a compound annual growth rate of -7.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 73.74M | 28.82% |
| Dec 30, 2025 | 57.25M | -45.34% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | 110.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synektik Spólka Akcyjna | 2.45B |
| Medinice | 321.78M |
| Medicalgorithmics | 295.10M |
| Nestmedic | 27.16M |
| InventionMed | 21.29M |
| Milton Essex Spólka Akcyjna | 11.56M |
| Zortrax | 8.57M |
| Adiuvo Investments | 7.88M |